Part of Novartis AG, Sandoz AG is a Swiss company located in Basel. The firm develops generic medicines and biosimilars.

LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS"​) and Oral Thin Films ("OTF"​) for the pharmaceutical industry. While we continuously refine our TTS and OTF technologies further, we also research complementary Micro Array Patches for the transdermal delivery of large molecule, biological actives. Incorporated in 1984, we operate today from two sites in Andernach, Germany and West Caldwell/NJ, USA, plus representative office in Shanghai/China.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Sichuan Credit Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of products related to central nervous system. Its products include capsules, tablets, freeze-dried powder injections, water injections, anti-tumor solid preparations, and traditional Chinese medicines. The company was founded on April 20, 2000 and is headquartered in Luzhou, China.

Laboratorios Senosiain SA de CV engages in the development and manufacture of pharmacetical products. These include antibiotics, suppositories, and analgesics. The company is based in Mexico City, Mexico.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder. At Braeburn, we challenge the status quo and champion transformation of the management of opioid use disorder (OUD) by partnering with the community to create a world where every person with OUD gets the best possible care and opportunity to reach their full potential.

FARMAK is a chemical-pharmaceutical company based in Olomouc.

Mdm SpA engages in wholesales and distributes pharmaceutical products. The company was founded in 1995 and is headquartered in Monza, Italy.

Jubilant Generics Ltd. engages in the manufacture and export of pharmaceutical products. The company is headquartered in Greater Noida, India.

Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI) and other disorders of the nervous system. The first product for which the Company completed clinical development, Ampyra (dalfampridine) Extended Release Tablets (Ampyra), was approved by the United States Food and Drug Administration (FDA) in January 2010, as a treatment to improve walking in patients with MS. Ampyra is an extended-release tablet formulation of dalfampridine (4-aminopyridine (4-AP)), which was previously referred to as fampridine. Acorda's marketed product, Zanaflex Capsules, is approved by the FDA as a short-acting drug for the management of spasticity.

Medrx Co. Ltd. engages in the business of pharmaceutical drug development based on the transdermal absorption. It develops new value-added medicines by the drug formulation technology based on ILTS (Ionic Liquid Transdermal System), a unique technologies using ionic liquid and unique transdermal drug delivery technology using nano-sized colloid transdermal system for drugs. The company was founded by Masayoshi Matsumura on January 15, 2002 and is headquartered in Higashikagawa, Japan.

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). They have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ.

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA.

Endo Pharmaceuticals Solutions, Inc. develops products to treat conditions in urology and endocrinology. The company was founded in 2009 and is headquartered in Malvern, PA.

Cypress Bioscience is a medical service provider that facilitates individualized patient care. The service provides its patients with therapeutic and personalized medical services in a variety of needs such as isolated areas of pain, rheumatology, and physical medicine and rehabilitation. It also addresses challenging disorders such as fibromyalgia and rheumatoid arthritis. Furthermore, the organization engages in the development of drugs such as Savella, a milnacipran HCI for the treatment of fibromyalgia, as well as Prosorba, a medical device for rheumatoid arthritis. Cypress Bioscience was founded in 1981 and is based in San Diego, California.

Luzhou Creed Pharmaceutical Co., Ltd., established on 2007-07-20, Business scope includes research and development of APIs,manufacture,Sales(Produced according to the specific range of varieties approved by the drug production license).Production,Sales of chemical intermediates,Plant extracts,Manage the chemical intermediates developed and produced by the company,Import and export trade business of plant extracts,Sales of chemical intermediates and plant extracts not produced by the company(The above business items do not include laws,Pre-approval and licensing items determined by regulations and the State Council).technology development,technology transfer,technical consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)